Navigation Links
ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
Date:6/9/2009

DUBLIN, June 9 /PRNewswire-FirstCall/ -- ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed a strategic partnership with Eli Lilly and Company (NYSE: LLY) to manage the company's clinical trial site set up and monitoring in Europe for Lilly managed studies. The agreement, which is subject to the relevant employee consultation processes, is a continuation of Lilly's ongoing transformation of its research and development organisation and follows Lilly's selection of ICON to manage its clinical data management business outside of the US, which was announced in November 2008.

"Today's announcement marks another milestone in the successful partnership between ICON and Lilly," commented Peter Gray, CEO at ICON. "We have worked together to create a truly flexible model that better meets Lilly's patient and portfolio needs and will also drive productivity within Lilly's clinical operations in Europe. We look forward to continuing to assist Lilly with its transformation initiatives and to delivering the quality services that will expedite their drug development pipelines."

"We are constantly evaluating how we can do things better to increase our flexibility and focus our internal efforts on our core capabilities," commented Jeff Kasher, Lilly Vice President and Chief Operating Officer of Global Clinical Development." This strategic agreement enables us to leverage ICON's significant expertise in clinical trial monitoring and site management in Europe and will increase our ability to speed innovative medicines to patients."

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has over 7,100 employees, operating from 71 locations in 38 countries.

Further information is available at http://www.iconplc.com

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

    ICON/ICLR-G

    US contact:
    Courtney Judd
    +1-212-445-8365
    cjudd@webershandwick.com

    UK contact:
    Erika Aalto
    +44(0)20-706-70-214
    eaalto@webershandwick.com



'/>"/>
SOURCE ICON plc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
5. Fry Construction Selected for High-Profile Medical Imaging Project
6. Meth Project Advertisements Selected for National Prevention Campaign
7. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
8. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
9. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
10. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
11. CBaySystems Selected to Receive Deloittes 2007 Maryland Technology Fast 50 Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2018)... ... September 01, 2018 , ... ... Elite to its leading menu of results-driven aesthetic treatments. HydraFacial is a ... of clinically-proven ingredients to dramatically improve your skin’s tone and texture for ...
(Date:9/1/2018)... , ... August 31, 2018 , ... SignatureCare Emergency Center ... awarded for the Fall semester to a deserving student. Get your applications in now ... scholarship was awarded to Hanna Wu who is a medical student at Texas Southern ...
(Date:8/31/2018)... ... , ... Becker's Healthcare is pleased to release the "100 ... as well as facilities affiliated with large health systems. Some hospitals serve expansive ... hospitals continue to grow in many communities, opening new departments and sites to ...
(Date:8/31/2018)... ... August 31, 2018 , ... The social impact documentary feature film ... Professor and NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has been faring ... on Film International Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, and ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... on the impact of a biofield energy treated nutraceutical to improve overall immunity ... for immune function and blood, as well as, inflammation. The following data was ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... Harris Teeter announced today it ... Hurricane Florence. , Throughout the month of September, the company invites their generous ... up their transaction to the nearest dollar to help support the American Red ...
(Date:9/13/2018)... , ... September 13, 2018 , ... ... and Hospice, effective August 31, 2018, making its regional Texas Home Health operations ... state including home health, hospice, and personal care services. , Texas Home ...
(Date:9/12/2018)... ... September 12, 2018 , ... Lifetime Wellness , a leading provider of ... of a new online store to offer exclusive aromatherapy products to a wider community. ... to open our online store to offer our custom aromatherapy to not only our ...
Breaking Medicine Technology: